Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Dec 30, 2021 4:27pm
170 Views
Post# 34272118

RE:I wanted to be CRYSTAL CLEAR as to why I call this stock

RE:I wanted to be CRYSTAL CLEAR as to why I call this stock
topadvisor1 wrote: an OUTIGHT 100% GAMBLE. Hoping that their clincal trials are successful is 100% GAMBLING, no and's if's or but's. Once this stock has positive results and has an ACTUAL PRODUCT IT CAN DISTRIBUTE, LICENSE AND SELL, than it MIGHT become and INVESTMENT. That from where I sit, is a long way off. I would rather pay 5 dollars for it later on when the real potential could be double or tripple, rather than pay .66 cents GUESSING if it will make it or go under. 


-----------------------

Good call Topadvisor but everyone should understand it didn't just become a gamble.  It's always been a gamble.  It's a gamble now.  It was a gamble in 2017 (at 8 cents).  It was a gamble before 2015 when the stock was halted on a Hep C scare.  It was gambling in 2009 when the boys hatched the H2S business idea.

Love to see those who are freaking out today ... they can't seem to find their footing on risk so they have to  blame others for their situation.  It's quite comical and it tellsyou what they really understand about ATE and themselves.  The loudest criers are the most out of their element. 

Nothing has changed in the way you should be looking at this company (except that we have much more data now - data that should be guiding the company's direction).

For those who are insiders and are buying shares ... they too are gambling but I guess society prefers to call them ... entrepreneurial.  Guess it's all the same for any start-up or early stage company - being entrepreneurial is a form of gambling.  That being said, those same cry babies who think management should be gambling on even more shares, aren't thinking about the fact that it's really a gamble for everyone.  Again ... comical.

As time goes by, we gain data and we improve our understanding.  We engage in what would be considered "calculated risk."  That's assuming the data is good - another aspect of the gamble that could land you in hot water.  Even if the data is good - have you covered all your bases?  But you may not know how many bases there are.  Another aspect of the gamble. 

There is nothing pretty about drug development.
There's no sure thing.
There's no silver bullet to success.

All you have is your instincts, the development team, their instincts, their limited understanding that gains traction with additional trials.  That's it !!!!!



In the words of gamblers ... Good Luck in 2022 !!!


<< Previous
Bullboard Posts
Next >>